Clinical Trials Browser

Not yet recruiting × HR+HER2- Breast Cancer × Clear all

NCT06639672 2024-10-15

Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer

Phase 2 Not yet recruiting

HR+HER2- Breast Cancer